SEC Tracker
Get the app

Cardiff Oncology CRDF

Cardiff Oncology: signs a material agreement and sells unregistered shares

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 10.1
Material contract
Exhibit 99.1
Press release
  • Signs a material agreement (1.01)
  • Sells unregistered shares (3.02)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Cardiff Oncology files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. Monte Rosa Therapeutics GLUE public float $212M, Jun 30, 2025
  2. Century Therapeutics IPSC public float $213M, Jun 30, 2025
  3. Lexeo Therapeutics LXEO public float $217M, Jun 30, 2025
  4. Editas Medicine EDIT public float $191M, Jun 30, 2025
  5. Liminatus Pharma LIMN public float $221M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.